628 results on '"Geiger, Tamar"'
Search Results
2. MinD-RNase E interplay controls localization of polar mRNAs in E. coli
Catalog
Books, media, physical & digital resources
3. Functional Impact of Protein–RNA Variation in Clinical Cancer Analyses
4. PDZD8 interacts with Protrudin and Rab7 at ER-late endosome membrane contact sites associated with mitochondria.
5. Tackling tumor complexity with single-cell proteomics
6. Space in cancer biology: its role and implications
7. MS-based technologies for untargeted single-cell proteomics
8. Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors
9. Disrupted neural correlates of anesthesia and sleep reveal early circuit dysfunctions in Alzheimer models
10. IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
11. Nascent Ribo-Seq measures ribosomal loading time and reveals kinetic impact on ribosome density
12. Proteogenomics of glioblastoma associates molecular patterns with survival
13. Distinct extracellular–matrix remodeling events precede symptoms of inflammation
14. Publisher Correction: Nascent Ribo-Seq measures ribosomal loading time and reveals kinetic impact on ribosome density
15. Spatiotemporal Proteomic Analysis of Stress Granule Disassembly Using APEX Reveals Regulation by SUMOylation and Links to ALS Pathogenesis
16. Abstract A048: Utero-tubal lavage proteomic analysis: detection of ovarian cancer in BRCA mutation carriers
17. Anti-tumour immunity induces aberrant peptide presentation in melanoma
18. Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues
19. Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
20. Systematic Detection of Amino Acid Substitutions in Proteomes Reveals Mechanistic Basis of Ribosome Errors and Selection for Translation Fidelity
21. Mitochondrial Regulation of the Hippocampal Firing Rate Set Point and Seizure Susceptibility
22. Identification of nucleolar protein NOM1 as a novel nuclear IGF1R-interacting protein
23. UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors
24. p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells
25. S101, an Inhibitor of Proliferating T Cells, Rescues Mice From Superantigen-Induced Shock
26. Phosphoproteomics reveals novel modes of function and inter‐relationships among PIKKs in response to genotoxic stress
27. Supplementary Figure 8 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
28. Supplementary Figure 3 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
29. Supplementary Figure 2 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
30. Supplementary Figure 5 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
31. Supplementary Figure 4 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
32. Supplementary Figure 1 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
33. Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research
34. Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome
35. Publisher Correction: Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome
36. Reversal of the Ras-Induced Transformed Phenotype by HR12, a Novel Ras Farnesylation Inhibitor, Is Mediated by the Mek/Erk Pathway
37. IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer
38. Table S4 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
39. Supplementary Figure Legends from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
40. Data from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
41. Supplementary Figure 6 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
42. Supplementary Figure 7 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
43. Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short‐term vs long‐term survivors of glioblastoma
44. MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
45. Supplementary Tables and Figures from MicroRNAs Affect Complement Regulator Expression and Mitochondrial Activity to Modulate Cell Resistance to Complement-Dependent Cytotoxicity
46. Supplementary Array S1 from MicroRNAs Affect Complement Regulator Expression and Mitochondrial Activity to Modulate Cell Resistance to Complement-Dependent Cytotoxicity
47. Data from MicroRNAs Affect Complement Regulator Expression and Mitochondrial Activity to Modulate Cell Resistance to Complement-Dependent Cytotoxicity
48. System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue Homeostasis
49. Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters
50. The landscape of tiered regulation of breast cancer cell metabolism
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.